The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis
Clinical trial NCT05772520 · COMPLETED
Trial details
- NCT number
- NCT05772520
- Sponsor
- Hangzhou Highlightll Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-19
- Primary completion
- 2024-12-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.